InsiderTrades.com logo
Investor Alert: EV Initiatives Create Unsustainable Demand For Lithium
From Investing Trends   |   Ad
The soaring demand for lithium is driven by worldwide demand for electric vehicles (EVs). Lithium is ideal for electric cars. It's lightweight, stores lots of energy and is rechargeable. Sales of EVs are expected to increase 10-fold by 2030 and estimates are that 1 in 2 cars sold will be electric by 2040.
See how EV demand is creating new opportunities

LCTX Insider Trading

Insider Ownership Percentage: 26.70%
Insider Buying (Last 12 Months): $83,887.00
Insider Selling (Last 12 Months): $1,228,890.60

Lineage Cell Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Lineage Cell Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lineage Cell Therapeutics Share Price & Price History

Current Price: $1.16
Price Change: ▼ Price Decrease of -0.02 (-1.69%)
As of 09/26/2022 03:08 PM ET

This chart shows the closing price history over time for LCTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Copper More Critical than Lithium?
From Investing Trends   |   Ad
Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found.
See How To Can Benefit From New Copper Discoveries

Lineage Cell Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/31/2022Brian M CulleyCEOBuy6,400$1.53$9,792.0097,787View SEC Filing Icon  
3/28/2022Dipti AminDirectorBuy35,000$1.63$57,050.00View SEC Filing Icon  
3/25/2022Brian M CulleyCEOBuy5,250$1.38$7,245.00View SEC Filing Icon  
3/24/2022Michael H MulroyDirectorBuy7,000$1.40$9,800.00View SEC Filing Icon  
12/28/2021Gary S HoggeSVPSell501,588$2.45$1,228,890.60View SEC Filing Icon  
6/29/2021Angus C. RussellDirectorSell4,720$2.97$14,018.4092,220View SEC Filing Icon  
See Full Table
Investor Alert: EV Initiatives Create Unsustainable Demand For Lithium
From Investing Trends   |   Ad
The soaring demand for lithium is driven by worldwide demand for electric vehicles (EVs). Lithium is ideal for electric cars. It's lightweight, stores lots of energy and is rechargeable. Sales of EVs are expected to increase 10-fold by 2030 and estimates are that 1 in 2 cars sold will be electric by 2040.
See how EV demand is creating new opportunities

SEC Filings (Institutional Ownership Changes) for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)

38.29% of Lineage Cell Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LCTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Lineage Cell Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/18/2022Goldman Sachs Group Inc.80,169$0.13M0.0%-37.1%0.047%Search for SEC Filing on Google Icon
8/16/2022Jane Street Group LLC58,977$93K0.0%-52.5%0.035%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD72,400$0.11M0.0%+18.5%0.043%Search for SEC Filing on Google Icon
8/15/2022State Street Corp440,096$0.70M0.0%-79.1%0.259%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC88,774$0.14M0.0%N/A0.052%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP2,422,367$3.83M0.1%N/A1.427%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC1,020,446$1.61M0.0%+471.7%0.601%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp201,775$0.32M0.0%-80.4%0.119%Search for SEC Filing on Google Icon
8/12/2022LPL Financial LLC239,320$0.38M0.0%+52.6%0.141%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.1,256,932$1.99M0.0%-32.0%0.741%Search for SEC Filing on Google Icon
8/10/2022Dowling & Yahnke LLC32,263$51K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/8/2022Y Intercept Hong Kong Ltd44,829$71K0.0%N/A0.026%Search for SEC Filing on Google Icon
8/8/2022Strategic Wealth Investment Group LLC49,736$79K0.0%-20.4%0.029%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.135,328$0.21M0.0%+1,027.7%0.080%Search for SEC Filing on Google Icon
8/2/2022Lincoln National Corp251,500$0.40M0.0%+30.4%0.148%Search for SEC Filing on Google Icon
7/26/2022Defender Capital LLC.5,131,935$8.11M3.2%+2.5%3.024%Search for SEC Filing on Google Icon
7/19/2022MAI Capital Management247,735$0.39M0.0%N/A0.146%Search for SEC Filing on Google Icon
6/7/2022Defender Capital LLC.5,006,185$7.98M2.8%+0.2%2.949%Search for SEC Filing on Google Icon
5/17/2022Mirabella Financial Services LLP18,800$29K0.0%N/A0.011%Search for SEC Filing on Google Icon
5/17/2022Jane Street Group LLC124,210$0.19M0.0%-60.1%0.073%Search for SEC Filing on Google Icon
5/17/2022Wealth Architects LLC16,100$25K0.0%N/A0.009%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System53,656$83K0.0%-20.8%0.032%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.127,432$0.20M0.0%+29.2%0.075%Search for SEC Filing on Google Icon
5/16/2022State Street Corp2,105,107$3.24M0.0%+1.5%1.240%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp1,030,809$1.59M0.0%-4.6%0.607%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.332,406$0.51M0.0%+5.4%0.196%Search for SEC Filing on Google Icon
5/13/2022DCF Advisers LLC53,000$82K0.0%-37.6%0.031%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.9,809,123$15.11M0.0%-2.0%5.779%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers101,742$0.16M0.0%-15.5%0.060%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp410,895$0.63M0.0%-2.5%0.242%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.1,849,662$2.85M0.0%+44.1%1.090%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP72,506$0.11M0.0%N/A0.043%Search for SEC Filing on Google Icon
5/10/2022Phoenix Holdings Ltd.111,545$0.17M0.0%-9.9%0.066%Search for SEC Filing on Google Icon
5/9/2022Principal Financial Group Inc.45,159$70K0.0%-42.6%0.027%Search for SEC Filing on Google Icon
5/9/2022Fort Sheridan Advisors LLC75,931$0.12M0.0%+43.5%0.045%Search for SEC Filing on Google Icon
4/28/2022DekaBank Deutsche Girozentrale402,100$0.61M0.0%+10.0%0.237%Search for SEC Filing on Google Icon
2/15/2022Raffles Associates LP543,590$1.33M1.3%+480.8%0.322%Search for SEC Filing on Google Icon
2/14/2022Long Focus Capital Management LLC215,000$0.53M0.1%N/A0.128%Search for SEC Filing on Google Icon
2/14/2022DAFNA Capital Management LLC80,000$0.20M0.0%N/A0.047%Search for SEC Filing on Google Icon
2/14/2022ETF Managers Group LLC207,735$0.52M0.0%N/A0.123%Search for SEC Filing on Google Icon
2/14/2022Williams Jones Wealth Management LLC.101,300$0.25M0.0%N/A0.060%Search for SEC Filing on Google Icon
2/10/2022Bailard Inc.63,400$0.16M0.0%N/A0.038%Search for SEC Filing on Google Icon
2/9/2022Principal Financial Group Inc.78,742$0.19M0.0%-36.6%0.047%Search for SEC Filing on Google Icon
2/9/2022Lazard Asset Management LLC21,610$52K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC27,397$67K0.0%+70.5%0.016%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp1,080,924$2.65M0.0%-27.8%0.641%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC31,542$77K0.0%-58.4%0.019%Search for SEC Filing on Google Icon
2/7/2022Phoenix Holdings Ltd.123,866$0.31M0.0%N/A0.073%Search for SEC Filing on Google Icon
2/2/2022DekaBank Deutsche Girozentrale365,500$0.89M0.0%-33.5%0.217%Search for SEC Filing on Google Icon
2/1/2022Defender Capital LLC.4,997,870$12.25M3.9%+4.2%2.965%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC522,913$1.28M0.0%N/A0.310%Search for SEC Filing on Google Icon
1/26/2022Straight Path Wealth Management16,200$40K0.0%N/A0.010%Search for SEC Filing on Google Icon
1/26/2022Lincoln National Corp193,500$0.47M0.0%+25.2%0.115%Search for SEC Filing on Google Icon
1/12/2022Value Partners Investments Inc.150,000$0.37M0.0%+25.0%0.089%Search for SEC Filing on Google Icon
1/10/2022Patriot Financial Group Insurance Agency LLC24,000$59K0.0%-36.8%0.014%Search for SEC Filing on Google Icon
12/8/2021Moors & Cabot Inc.18,400$47K0.0%-21.2%0.011%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP1,112,366$2.80M0.0%-39.0%0.664%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP580,788$1.46M0.0%-55.8%0.347%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Securities LLC96,762$0.24M0.0%N/A0.058%Search for SEC Filing on Google Icon
11/16/2021Metropolitan Life Insurance Co NY19,078$48K0.0%-50.7%0.011%Search for SEC Filing on Google Icon
11/15/2021HighTower Advisors LLC33,316$84K0.0%+104.2%0.020%Search for SEC Filing on Google Icon
11/12/2021Laidlaw Wealth Management LLC104,841$0.26M0.1%-15.3%0.063%Search for SEC Filing on Google Icon
11/12/2021E Fund Management Co. Ltd.11,095$28K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.97,071$0.25M0.0%+625.8%0.058%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.137,858$0.35M0.0%+1,082.0%0.082%Search for SEC Filing on Google Icon
11/10/2021Rafferty Asset Management LLC193,756$0.49M0.0%N/A0.116%Search for SEC Filing on Google Icon
11/9/2021Morgan Jess S & Co. Inc.15,000$38K0.0%N/A0.009%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.8,551,700$21.55M0.0%+0.1%5.107%Search for SEC Filing on Google Icon
11/9/2021Principal Financial Group Inc.124,219$0.31M0.0%-3.5%0.074%Search for SEC Filing on Google Icon
11/5/2021Lincoln National Corp154,600$0.39M0.0%N/A0.092%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund69,150$0.17M0.0%-33.4%0.041%Search for SEC Filing on Google Icon
11/1/2021Defender Capital LLC.4,798,270$12.71M4.1%-4.7%2.865%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC75,780$0.19M0.0%N/A0.045%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC43,939$0.11M0.0%-19.1%0.026%Search for SEC Filing on Google Icon
10/28/2021WINTON GROUP Ltd62,869$0.16M0.0%+17.3%0.038%Search for SEC Filing on Google Icon
10/25/2021Sightline Wealth Advisors LLC14,958$38K0.0%N/A0.009%Search for SEC Filing on Google Icon
10/6/2021IFP Advisors Inc11,077$28K0.0%+260.0%0.007%Search for SEC Filing on Google Icon
10/5/2021LVM Capital Management Ltd. MI10,000$25K0.0%N/A0.006%Search for SEC Filing on Google Icon
9/24/2021Thrivent Financial for Lutherans42,670$0.12M0.0%N/A0.025%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC54,131$0.15M0.0%N/A0.032%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP186,940$0.53M0.0%N/A0.112%Search for SEC Filing on Google Icon
8/19/2021Thrivent Financial for Lutherans42,670$0.12M0.0%N/A0.025%Search for SEC Filing on Google Icon
8/17/2021Metropolitan Life Insurance Co NY38,709$0.11M0.0%N/A0.023%Search for SEC Filing on Google Icon
8/17/2021MetLife Investment Management LLC50,559$0.14M0.0%N/A0.030%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD53,731$0.15M0.0%+22.7%0.032%Search for SEC Filing on Google Icon
8/17/2021Bel Air Investment Advisors LLC17,000$48K0.0%N/A0.010%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC596,427$1.70M0.0%-7.3%0.357%Search for SEC Filing on Google Icon
8/16/2021Amalgamated Bank17,067$49K0.0%N/A0.010%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC47,500$0.14M0.0%-66.9%0.028%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System167,396$0.48M0.0%N/A0.100%Search for SEC Filing on Google Icon
8/16/2021Pinz Capital Management LP9,100$26K0.0%N/A0.005%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.322,361$0.92M0.0%+569.3%0.193%Search for SEC Filing on Google Icon
8/16/2021State Street Corp1,868,046$5.32M0.0%+2,745.3%1.117%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC449,911$1.28M0.0%N/A0.269%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP186,940$0.53M0.0%N/A0.112%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp1,628,749$4.64M0.0%+449.7%0.974%Search for SEC Filing on Google Icon
8/13/2021LPL Financial LLC60,380$0.17M0.0%+26.8%0.036%Search for SEC Filing on Google Icon
8/13/2021DCF Advisers LLC74,500$0.21M0.1%+254.8%0.045%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC2,338,584$6.66M0.0%+84.7%1.399%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.6,398,815$18.24M0.0%+15.1%3.828%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Lineage Cell Therapeutics logo
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also offers Renevia, a facial aesthetics product. In addition, the company engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Orbit Biomedical, Ltd. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.
Read More on Lineage Cell Therapeutics

Today's Range

Now: $1.16
Low: $1.14
High: $1.16

50 Day Range

MA: N/A

52 Week Range

Now: $1.16
Low: $1.10
High: $2.71

Volume

796 shs

Average Volume

721,927 shs

Market Capitalization

$196.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59

Who are the company insiders with the largest holdings of Lineage Cell Therapeutics?

Lineage Cell Therapeutics' top insider investors include:
  1. Brian M Culley (CEO)
  2. Angus C Russell (Director)
  3. Dipti Amin (Director)
  4. Gary S Hogge (SVP)
  5. Michael H Mulroy (Director)
Learn More about top insider investors at Lineage Cell Therapeutics.

Who are the major institutional investors of Lineage Cell Therapeutics?

Lineage Cell Therapeutics' top institutional shareholders include:
  1. Defender Capital LLC. — 3.02%
  2. Laurion Capital Management LP — 1.43%
  3. JPMorgan Chase & Co. — 0.74%
  4. Millennium Management LLC — 0.60%
  5. State Street Corp — 0.26%
  6. Lincoln National Corp — 0.15%
Learn More about top institutional investors of Lineage Cell Therapeutics stock.

Which major investors are selling Lineage Cell Therapeutics stock?

Within the previous quarter, LCTX stock was sold by these institutional investors:
  1. State Street Corp
  2. Northern Trust Corp
  3. JPMorgan Chase & Co.
  4. Jane Street Group LLC
  5. Goldman Sachs Group Inc.
  6. Strategic Wealth Investment Group LLC
  7. Group One Trading L.P.

Which major investors are buying Lineage Cell Therapeutics stock?

During the previous quarter, LCTX stock was acquired by institutional investors including:
  1. Laurion Capital Management LP
  2. Millennium Management LLC
  3. MAI Capital Management
  4. Defender Capital LLC.
  5. Connor Clark & Lunn Investment Management Ltd.
  6. Cubist Systematic Strategies LLC
  7. LPL Financial LLC
  8. Lincoln National Corp
Within the previous year, these company insiders have bought Lineage Cell Therapeutics stock:
  1. Brian M Culley (CEO)
  2. Angus C Russell (Director)
  3. Dipti Amin (Director)
Learn More investors buying Lineage Cell Therapeutics stock.
Investor Alert: EV Initiatives Create Unsustainable Demand For Lithium
From Investing Trends   |   Ad
The soaring demand for lithium is driven by worldwide demand for electric vehicles (EVs). Lithium is ideal for electric cars. It's lightweight, stores lots of energy and is rechargeable. Sales of EVs are expected to increase 10-fold by 2030 and estimates are that 1 in 2 cars sold will be electric by 2040.
See how EV demand is creating new opportunities